We are live on ! Find out more
IAM

Innovis Asset Management Portfolio holdings

AUM $260M
1-Year Est. Return 28.13%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+28.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$221M
AUM Growth
Cap. Flow
+$226M
Cap. Flow %
102.05%
Top 10 Hldgs %
36.58%
Holding
150
New
150
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$17.3M
2
UNH icon
UnitedHealth
UNH
+$9.28M
3
HES
Hess
HES
+$7.94M
4
PFE icon
Pfizer
PFE
+$7.42M
5
P
Everpure Inc
P
+$7.09M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 27.74%
2 Healthcare 24.27%
3 Financials 11.21%
4 Energy 10.63%
5 Consumer Discretionary 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUPH icon
126
Aurinia Pharmaceuticals
AUPH
$2.11B
$247K 0.11%
+57,263
New +$332K
FTNT icon
127
Fortinet
FTNT
$117B
$238K 0.11%
+4,875
New +$254K
VYM icon
128
Vanguard High Dividend Yield ETF
VYM
$82.8B
$237K 0.11%
+2,194
New +$233K
EVLV icon
129
Evolv Technologies
EVLV
$1.1B
$227K 0.1%
+87,818
New +$258K
GOOG icon
130
Alphabet (Google) Class C
GOOG
$4.32T
$227K 0.1%
+2,560
New +$244K
WMT icon
131
Walmart Inc
WMT
$890B
$227K 0.1%
+4,800
New +$228K
PENN icon
132
PENN Entertainment
PENN
$2.71B
$221K 0.1%
+7,455
New +$242K
IJH icon
133
iShares Core S&P Mid-Cap ETF
IJH
$127B
$213K 0.1%
+4,400
New +$213K
CROX icon
134
Crocs
CROX
$6.55B
$208K 0.09%
+1,921
New +$170K
CADE
135
DELISTED
Cadence Bank
CADE
$201K 0.09%
+8,161
New +$219K
GFI icon
136
Gold Fields
GFI
$36.5B
$201K 0.09%
+19,382
New +$188K
PRTS icon
137
CarParts.com
PRTS
$54.7M
$191K 0.09%
+3,046
New +$160K
TARS icon
138
Tarsus Pharmaceuticals
TARS
$2.84B
$190K 0.09%
+12,981
New +$215K
HBNC icon
139
Horizon Bancorp
HBNC
$1.04B
$183K 0.08%
+12,114
New +$200K
XAIR icon
140
Beyond Air
XAIR
$3.86M
$177K 0.08%
+68
New +$174K
ATEN icon
141
A10 Networks
ATEN
$1.95B
$172K 0.08%
+10,360
New +$178K
ASPN icon
142
Aspen Aerogels
ASPN
$518M
$169K 0.08%
+14,351
New +$164K
TRVI icon
143
Trevi Therapeutics
TRVI
$2.64B
$169K 0.08%
+87,453
New +$172K
KURA icon
144
Kura Oncology
KURA
$850M
$166K 0.08%
+13,404
New +$195K
CTKB icon
145
Cytek Biosciences
CTKB
$546M
$149K 0.07%
+14,565
New +$196K
NVTA
146
DELISTED
Invitae Corporation
NVTA
$116K 0.05%
+62,476
New +$153K
SPOK icon
147
Spok Holdings
SPOK
$241M
$102K 0.05%
+12,473
New +$101K
EOSE icon
148
Eos Energy Enterprises
EOSE
$1.51B
$97.5K 0.04%
+65,886
New +$85.4K
ERAS icon
149
Erasca
ERAS
$6.39B
$96.4K 0.04%
+22,356
New +$152K
GBIO
150
DELISTED
Generation Bio
GBIO
$78.9K 0.04%
+2,007
New +$105K

Similar funds

Innovis Asset Management's Q4 2022 Portfolio in Review

Q4 2022 is the first quarter with a 13F filing on record for Innovis Asset Management, which disclosed 150 positions worth $221M. Its ten largest holdings account for 37% of the portfolio.

Its largest position is Apple: 120,896 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, followed by Healthcare and Financials.

  • Innovis Asset Management's largest Q4 2022 buy was Apple: 120,896 shares worth $15.7M.
  • Innovis Asset Management's ten largest holdings make up 37% of its $221M portfolio in Q4 2022.
  • Innovis Asset Management disclosed 150 positions in Q4 2022, its first 13F filing on record.

Based on Innovis Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.